

10 Dec 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212369

02 May 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212420

17 Aug 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212449

08 Sep 2021
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212463

24 Nov 2018
// PATENT LITIGATION

16 Oct 2018
// FDA
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-cerdelga-eliglustat-tablets-1539771276.pdf